Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
Status:
Completed
Trial end date:
2008-10-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a single intravenous (IV) dose of palonosetron
0.25 mg plus a single IV dose of dexamethasone 8 mg is effective to prevent nausea and
vomiting induced by moderately emetogenic chemotherapy in subjects with cancer.